Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
– Topline data from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025 – – Breakthrough Therapy Designation granted for ziftomenib in R/R NPM1-mutant AML – –...
– Preclinical data suggest combination of ziftomenib and imatinib has potential to resensitize patients to imatinib and induce durable responses – – Proof-of-concept study evaluating ziftomenib...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.72 | 3.68474923234 | 19.54 | 21.36 | 19.26 | 363602 | 20.33994995 | CS |
4 | 0.15 | 0.745897563401 | 20.11 | 21.569 | 19.12 | 397803 | 20.07909836 | CS |
12 | -0.13 | -0.637567435017 | 20.39 | 23.48 | 17.915 | 630924 | 20.25406475 | CS |
26 | -1.96 | -8.82088208821 | 22.22 | 23.48 | 16.79 | 690223 | 20.38406341 | CS |
52 | 10.41 | 105.685279188 | 9.85 | 24.17 | 7.41 | 948541 | 17.12325099 | CS |
156 | -0.38 | -1.84108527132 | 20.64 | 24.17 | 7.41 | 832688 | 15.06664614 | CS |
260 | 3.79 | 23.0115361263 | 16.47 | 43 | 6.34 | 736073 | 17.91593627 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.